Clinical Manifestations Differ Between Interstitial Cystitis, Bladder Pain Syndrome
By Lori Solomon HealthDay Reporter
FRIDAY, Jan. 3, 2025 -- Interstitial cystitis and bladder pain syndrome (IC/BPS) vary in clinical manifestation, according to a study published online Oct. 18 in the International Journal of Urology.
Aya Niimi, M.D., Ph.D., from the University of Tokyo, and colleagues used patient registry data to describe clinical manifestations of patients with IC and BPS. The analysis included data from 529 patients seen at 14 university hospitals.
According to the researchers, 66.5 percent of the cases were classified as IC and 33.5 percent as BPS. IC patients were significantly older, were more likely female, and had more prevalent comorbidities, including autoimmune diseases. IC patients had significantly worse symptom severity, quality-of-life impairment, and bladder function. Urinary frequency on the frequency-volume chart was 18.8 times and 15.0 times higher for IC and BPS patients, respectively, and maximum voided volume was 160.9 and 214.1 mL, respectively. Bladder capacity under anesthesia was 293.8 and 472.6 mL, respectively. Pain in IC patients was significantly predicted by maximum voided volume and the number of Hunner lesions.
"This large-scale study highlighted different characteristics of IC and BPS, providing useful information to understand the etiology and management of IC/BPS," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-04 06:00
Read more
- Genentech’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson’s Disease
- 1 in 5 Adults With Long Covid Struggle With Daily Activities
- The Most Therapeutic Kind of Me-Time
- Sepsis Care Guided by Daily Procalcitonin Cuts Antibiotic Duration
- FDA Asks Biden Administration to Limit Nicotine in Tobacco Products
- Psychologists ID Financial, Administrative Barriers to Accepting Insurance
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions